Rapamycin, proliferation and geroconversion to senescence

被引：42

作者：

Blagosklonny, Mikhail V. ^{[1
]}

机构：

[1] Roswell Park Canc Inst, Cell Stress Biol, Buffalo, NY 14263 USA

来源：

CELL CYCLE | 2018年 / 17卷 / 24期

关键词：

Aging; gero-suppressants; senolytics; rapalogs; cancer; SASP;

D O I：

10.1080/15384101.2018.1554781

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Rapamycin inhibits cell proliferation, yet preserves (re)-proliferative potential (RPP). RPP is a potential of quiescent cells that is lost in senescent cells. mTOR drives conversion from quiescence to senescence (geroconversion). By suppressing geroconversion, rapamycin preserves RPP. Geroconversion is characterized by proliferation-like levels of phospho-S6K/S6/4E-BP1 in nonproliferating cells arrested by p16 and/or p21. mTOR-driven geroconversion is associated with cellular hyperfunction, which in turn leads to organismal aging manifested by age-related diseases.

引用

页码：2655 / 2665

页数：11

共 143 条

[1] Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence [J].

Aarts, Marieke ;

Georgilis, Athena ;

Beniazza, Meryam ;

Beolchi, Patrizia ;

Banito, Ana ;

Carroll, Thomas ;

Kulisic, Marizela ;

Kaemena, Daniel F. ;

Dharmalingam, Gopuraja ;

Martin, Nadine ;

Reik, Wolf ;

Zuber, Johannes ;

Kaji, Keisuke ;

Chandra, Tamir ;

Gil, Jesus .

GENES & DEVELOPMENT, 2017, 31 (20) :2085-2098

[2]

ALBERS MW, 1993, J BIOL CHEM, V268, P22825

[3] Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice [J].

Anisimov, Vladimir N. ;

Zabezhinski, Mark A. ;

Popovich, Irina G. ;

Piskunova, Tatiana S. ;

Semenchenko, Anna V. ;

Tyndyk, Margarita L. ;

Yurova, Maria N. ;

Rosenfeld, Svetlana V. ;

Blagosklonny, Mikhail V. .

CELL CYCLE, 2011, 10 (24) :4230-4236

[4] Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice [J].

Anisimov, Vladimir N. ;

Zabezhinski, Mark A. ;

Popovich, Irina G. ;

Piskunova, Tatiana S. ;

Semenchenko, Anna V. ;

Tyndyk, Margarita L. ;

Yurova, Maria N. ;

Antoch, Marina P. ;

Blagosklonny, Mikhail V. .

AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) :2092-2097

[5] AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy [J].

Astle, M. V. ;

Hannan, K. M. ;

Ng, P. Y. ;

Lee, R. S. ;

George, A. J. ;

Hsu, A. K. ;

Haupt, Y. ;

Hannan, R. D. ;

Pearson, R. B. .

ONCOGENE, 2012, 31 (15) :1949-1962

[6] Differential anti-inflammatory effects of immunosuppressive drugs:: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production [J].

Attur, MG ;

Patel, R ;

Thakker, G ;

Vyas, P ;

Levartovsky, D ;

Patel, P ;

Naqvi, S ;

Raza, R ;

Patel, K ;

Abramson, D ;

Bruno, G ;

Abramson, SB ;

Amin, AR .

INFLAMMATION RESEARCH, 2000, 49 (01) :20-26

[7] Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1 [J].

Averous, J. ;

Fonseca, B. D. ;

Proud, C. G. .

ONCOGENE, 2008, 27 (08) :1106-1113

[8] ZRF1 is a novel S6 kinase substrate that drives the senescence programme [J].

Barilari, Manuela ;

Bonfils, Gregory ;

Treins, Caroline ;

Koka, Vonda ;

De Villeneuve, Delphine ;

Fabrega, Sylvie ;

Pende, Mario .

EMBO JOURNAL, 2017, 36 (06) :736-750

[9] Reversal of human cellular senescence:: roles of the p53 and p16 pathways [J].

Beauséjour, CM ;

Krtolica, A ;

Galimi, F ;

Narita, M ;

Lowe, SW ;

Yaswen, P ;

Campisi, J .

EMBO JOURNAL, 2003, 22 (16) :4212-4222

[10] A novel transcriptional inhibitory element differentially regulates the cyclin D1 gene in senescent cells [J].

Berardi, P ;

Meyyappan, M ;

Riabowol, KT .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7510-7519

← 1 2 3 4 5 6 7 8 9 10 →